GB/T 16886.1-2011
Biological evaluation of medical devices.Part 1: Evaluation and testing within a risk management process (English Version)

Standard No.
GB/T 16886.1-2011
Language
Chinese, Available in English version
Release Date
2011
Published By
General Administration of Quality Supervision, Inspection and Quarantine of the People‘s Republic of China
Status
 2023-05
Replace By
GB/T 16886.1-2022
Latest
GB/T 16886.1-2022
Replace
GB/T 16886.1-2001
Scope
This part of GB/T 16886 describes: - the basic principles guiding the biological evaluation of medical devices within the framework of medical device risk management; - a general classification according to the nature and duration of contact between the device and the human body; - a summary of relevant data from all sources Evaluation; - identification of deficiencies in available data sets based on risk analysis; - identification of other data sets required for biological safety analysis of medical devices; - assessment of biological safety of medical devices. This section does not include experiments on materials and devices that are not in direct or indirect contact with the patient's body, nor does it include any biological hazards caused by mechanical failure. Specific tests included in other parts of GB/T 16886 are given in the preface.

GB/T 16886.1-2011 Referenced Document

  • ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • ISO 10993-2 Biological evaluation of medical devices — Part 2: Animal welfare requirements*2022-11-03 Update
  • ISO 10993-3 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity*2014-10-01 Update
  • ISO 10993-4 Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood — Amendment 1
  • ISO 10993-5 Biological evaluation of medical devices — Part 5: Tests for cytotoxicity: in vitro methods
  • ISO 10993-6 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation*2016-12-01 Update
  • ISO 10993-7 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals; Technical Corrigendum 1
  • ISO 10993-9 Biological evaluation of medical devices — Part 9: Framework for identification and quantification of potential degradation products*2019-11-26 Update
  • ISO 14971 Medical devices - Application of risk management to medical devices*2019-12-01 Update

GB/T 16886.1-2011 history

  • 2022 GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process
  • 2011 GB/T 16886.1-2011 Biological evaluation of medical devices.Part 1: Evaluation and testing within a risk management process
  • 2001 GB/T 16886.1-2001 Biological evaluation of medical devices--Part 1: Evaluation and testing

GB/T 16886.1-2011 Biological evaluation of medical devices.Part 1: Evaluation and testing within a risk management process was changed to FZ/T 54038-2014 Profiled polyester drawn textured yarns.

Biological evaluation of medical devices.Part 1: Evaluation and testing within a risk management process

GB/T 16886.1-2011 -All Parts

GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process GB/T 16886.10-2017 Biological evaluation of medical devices—Part 10: Tests for irritation and skin sensitization GB/T 16886.11-2021 Biological evaluation of medical devices—Part 11: Tests for systemic toxicity GB/T 16886.12-2023 Biological Evaluation of Medical Devices Part 12: Sample Preparation and Reference Materials GB/T 16886.13-2017 Biological evaluation of medical devices—Part 13: Identification and quantification of degradation products from polymeric medical devices GB/T 16886.14-2003 Biological evaluation of medical devices--Part 14: Identification and quantification of degradation products from ceramics GB/T 16886.15-2022 Biological evaluation of medical devices—Part 15: Identification and quantification of degradation products from metals and alloys GB/T 16886.16-2021 Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables GB/T 16886.17-2005 Biological evaluation of medical devices.Part 17:Establishment of allowable limits for leachable substances GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process GB/T 16886.19-2022 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials GB/T 16886.2-2011 Biological evaluation of medical devices.Part 2: Animal welfare requirements GB/T 16886.20-2015 Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices GB/T 16886.23-2023 Biological Evaluation of Medical Devices Part 23: Stimulation Test GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity GB/T 16886.4-2022 Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood GB/T 16886.5-2017 Biological Evaluation of Medical Devices Part 5: In Vitro Cytotoxicity Tests GB/T 16886.6-2022 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation GB/T 16886.7-2015 Biological evaluation of medical devices—Part 7: Ethylene oxide sterilization residuals GB/T 16886.9-2022 Biological Evaluation of Medical Devices Part 9: Qualitative and Quantitative Framework for Potential Degradation Products



Copyright ©2024 All Rights Reserved